Assessment Of The Inhalation Profiles Of Four Dry Powder Inhalers In Patients With Variable Degrees Of Lung Obstruction
NCT01033669 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 57
Last updated 2010-03-17
Summary
Assessment of the inhalation profiles of four dry powder inhalers in patients with variable degrees of lung obstruction
Conditions
- Asthma
- Pulmonary Disease, Chronic Obstructive
Interventions
- DEVICE
-
CRC-749
There is no drug being used. This is a device.
- DEVICE
-
Diskus
There is no drug being used. This is a device.
- DEVICE
-
Twisthaler
There is no drug being used. This is a device.
- DEVICE
-
Miat Monohaler
There is no drug being used. This is a device.
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-11-30
- Primary Completion
- 2010-02-28
- Completion
- 2010-02-28
Countries
- Germany
Study Locations
More Related Trials
-
Pharmacokinetic Study Comparing Salmeterol/Fluticasone Easyhaler and Seretide Diskus
NCT03060044 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Tiotropium and Atrovent in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
NCT02172469 ·Status: COMPLETED ·Phase: PHASE3
-
Combivent Respimat 1-year Safety Study in Patients With Chronic Obstructive Pulmonary Disease
NCT01019694 ·Status: COMPLETED ·Phase: PHASE3
-
Exercise Study in Patient With Chronic Obstructive Pulmonary Disease (0000-036)
NCT00387036 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety of Tiotropium Inhalation Capsules and Atrovent MDI in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT00274092 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial to Assess the Pharmacodynamic Response in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
NCT01168310 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Characterizing Pharmacodynamic Profiles in Subjects With Chronic Obstructive Pulmonary Disease
NCT01113593 ·Status: COMPLETED ·Phase: PHASE2
-
Inhaled Corticosteroid Withdrawal in Patients With Chronic Obstructive Pulmonary Disease
NCT00975195 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Tiotropium Inhalation Capsules and Atrovent Metered Dose Inhaler (MDI) in a Efficacy and Safety Study in Adults With Chronic Obstructive Pulmonary Disease
NCT02172443 ·Status: COMPLETED ·Phase: PHASE3
-
The Asthma Bronchial Challenge Study
NCT03575663 ·Status: COMPLETED
-
Safety, Toleration and Efficacy of Single Inhaled Doses of PF-00610355 in Chronic Obstructive Pulmonary (COPD) Patients.
NCT00783406 ·Status: COMPLETED ·Phase: PHASE2
-
Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease
NCT01040689 ·Status: COMPLETED ·Phase: PHASE3
-
Trial Comparing Tiotropium Inhalation Capsules vs Placebo in Chronic Obstructive Pulmonary Disease (COPD).
NCT00523991 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Fixed Combination of Beclomethasone Dipropionate (BDP) + Formoterol Fumarate (FF) + Glycopyrronium Bromide (GB) (CHF 5993)Administered Via Dry Powder Inhaler (DPI) in Chronic Obstructive Pulmonary Disease (COPD)
NCT03590379 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy, Pharmacokinetics and Safety Comparison of Salmeterol Inhalation Powder Administered Via the HandiHaler® 2 and Serevent® Diskus® in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT02242227 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25mcg Once Daily Compared With Tiotropium Bromide Inhalation Powder 18mcg Once Daily in Subjects With COPD Who Have or Are At Risk for Co-morbid Cardiovascular Disease
NCT01627327 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized, Double-Blind, 4-way Crossover Study to Evaluate the Efficacy of of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease
NCT01040728 ·Status: COMPLETED ·Phase: PHASE3
-
Influence Of Different Airflow Resistances On Drug Effect Of 50μg Salmeterol And 6 μg Formoterol
NCT00327353 ·Status: COMPLETED ·Phase: PHASE4
-
Inhalation Flow Rate-study
NCT02563197 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety Study of Beclometasone/Formoterol Single Inhaler in Patients With COPD
NCT00476099 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Evaluating Systemic Exposure and Pharmacodynamics in Patients With Chronic Obstructive Pulmonary Disease
NCT00774761 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Salmeterol and Fluticasone Propionate Absorption From Salmeterol/Fluticasone Easyhaler With Seretide Diskus
NCT01856621 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetic (PK), and Pharmacodynamic (PD) Profiles of 3 Doses of Fluticasone Furoate (FF)/GW642444 Inhalation Powder at the End of a 28-day Treatment Period in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Compared to Placebo
NCT01072149 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating Preference, Satisfaction and Ease of Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD) Diagnosed Patients
NCT01385696 ·Status: COMPLETED ·Phase: PHASE3
-
Salmeterol/Fluticasone Easyhaler in the Treatment of Asthma and COPD
NCT03755544 ·Status: COMPLETED